Search

Search Constraints

You searched for: Author/Creator Aikawa, Nadia E

Search Results

1. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Issue 6 (2nd May 2011)

2. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study. (February 2022)

3. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome. (July 2022)

4. Pandemic non-adjuvanted influenza A H1N1 vaccine in a cohort of patients with systemic sclerosis. (8th September 2017)

5. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice. Issue 12 (22nd August 2011)

6. Risk factors for mortality in 1528 Brazilian childhood-onset systemic lupus erythematosus patients. (May 2023)

7. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study. Issue 5 (May 2022)

9. Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine. (26th May 2022)

10. The new 2019-EULAR/ACR classification criteria specific domains at diagnosis can predict damage accrual in 670 childhood-onset systemic lupus erythematosus patients. (December 2021)